HomeCompareEBSB vs MRK

EBSB vs MRK: Dividend Comparison 2026

EBSB yields 6.13% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EBSB wins by $20010.34M in total portfolio value
10 years
EBSB
EBSB
● Live price
6.13%
Share price
$24.15
Annual div
$1.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20010.39M
Annual income
$19,402,197,253.49
Full EBSB calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EBSB vs MRK

📍 EBSB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEBSBMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EBSB + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EBSB pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EBSB
Annual income on $10K today (after 15% tax)
$520.91/yr
After 10yr DRIP, annual income (after tax)
$16,491,867,665.47/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EBSB beats the other by $16,491,859,337.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EBSB + MRK for your $10,000?

EBSB: 50%MRK: 50%
100% MRK50/50100% EBSB
Portfolio after 10yr
$10005.23M
Annual income
$9,701,103,525.82/yr
Blended yield
96.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EBSB
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EBSB buys
0
MRK buys
0
No recent congressional trades found for EBSB or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEBSBMRK
Forward yield6.13%2.76%
Annual dividend / share$1.48$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$20010.39M$56.8K
Annual income after 10y$19,402,197,253.49$9,798.13
Total dividends collected$19968.30M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: EBSB vs MRK ($10,000, DRIP)

YearEBSB PortfolioEBSB Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,926$1,225.67$11,206$366.19+$720.00EBSB
2$15,493$2,732.14$12,650$502.35+$2.8KEBSB
3$23,211$6,634.25$14,407$694.19+$8.8KEBSB
4$43,415$18,578.62$16,585$967.82+$26.8KEBSB
5$111,406$64,952.65$19,342$1,363.89+$92.1KEBSB
6$430,746$311,541.57$22,913$1,947.19+$407.8KEBSB
7$2,712,407$2,251,508.64$27,662$2,823.89+$2.68MEBSB
8$29,402,712$26,500,435.94$34,159$4,173.35+$29.37MEBSB
9$568,408,257$536,947,354.92$43,337$6,308.80+$568.36MEBSB
10$20,010,394,088$19,402,197,253.49$56,776$9,798.13+$20010.34MEBSB

EBSB vs MRK: Complete Analysis 2026

EBSBStock

Meridian Bancorp, Inc. operates as the holding company for East Boston Savings Bank that provides various financial products and services for individuals and businesses primarily in Suffolk, Norfolk, Middlesex, and Essex Counties, Massachusetts. The company accepts various deposit products, including non-interest-bearing demand deposits, such as checking accounts; interest-bearing demand accounts, such as NOW and money market accounts; savings accounts; and certificates of deposit, as well as commercial checking accounts. Its loan portfolio includes commercial real estate loans, which are secured by properties, such as office buildings, industrial facilities, and retail facilities; one- to four-family residential loans, such as mortgage loans that enable borrowers to purchase or refinance existing homes; multi-family real estate loans; construction loans; commercial and industrial loans; home equity lines of credit; and consumer loans, including automobile loans, loans secured by savings or certificate accounts, credit builders, and annuity and overdraft loans. In addition, the company offers non-deposit financial products, such as mutual funds, annuities, stocks, and bonds through third-party broker-dealer; and long-term care insurance products. It is also involved in the securities transactions business. The company operates 42 full-service locations, one mobile branch, and three loan centers. Meridian Bancorp, Inc. was founded in 1848 and is based in Peabody, Massachusetts.

Full EBSB Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EBSB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EBSB vs SCHDEBSB vs JEPIEBSB vs OEBSB vs KOEBSB vs MAINEBSB vs JNJEBSB vs ABBVEBSB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.